CONMED
CNMD
$49.25
Share price
-1.38%
Change (1 day)
-33.08%
Change (1 year)
Categories
P/S ratio for CONMED (CNMD)
P/S ratio as of July 2025 (TTM): 1.16
According to CONMED's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.56. At the end of 2025 the company had a P/S ratio of 1.38.
P/S ratio history for CONMED from 2001 to 2025
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2025 | 1.38 | -17.19% |
| 2024 | 1.67 | -38.31% |
| 2023 | 2.71 | 4.68% |
| 2022 | 2.58 | -37% |
| 2021 | 4.10 | 10.45% |
| 2020 | 3.71 | 11.61% |
| 2019 | 3.33 | 58.4% |
| 2018 | 2.10 | 17.52% |
| 2017 | 1.79 | 11.07% |
| 2016 | 1.61 | -5.16% |
| 2015 | 1.70 | 1.17% |
| 2014 | 1.68 | 8.3% |
| 2013 | 1.55 | 49.84% |
| 2012 | 1.03 | 4.59% |
| 2011 | 0.9884 | -5.42% |
| 2010 | 1.05 | 9.25% |
| 2009 | 0.9566 | 2.19% |
| 2008 | 0.9361 | -1.75% |
| 2007 | 0.9528 | -4.75% |
| 2006 | 1.00 | -7.43% |
| 2005 | 1.08 | -26.74% |
| 2004 | 1.47 | 5.86% |
| 2003 | 1.39 | 12% |
| 2002 | 1.24 | 5.93% |
| 2001 | 1.17 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | 8.82 | 661.76% | 🇺🇸 USA |
 Smith & Nephew
SNN | 2.83 | 144.54% | 🇬🇧 UK |
 Teleflex TFX | 1.67 | 44.01% | 🇺🇸 USA |
 Medtronic MDT | 3.42 | 195.40% | 🇮🇪 Ireland |
 Integra LifeSciences IART | 0.5732 | -50.50% | 🇺🇸 USA |
 Stryker Corporation SYK | 6.40 | 452.83% | 🇺🇸 USA |
 Johnson & Johnson JNJ | 4.39 | 279.11% | 🇺🇸 USA |